A precision medicine classification for treatment of acute myeloid leukemia in older patients
      QxMD      Google Scholar   
Citation:
J Hematol Oncol vol 14 (1) 96
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
10
Parents:
2993  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, UG1CA189823, U10CA180882, U24CA196171, UG1CA233338, UG1CA233331, P50CA140158, U10CA180861, P30CA016058, R35 CA198183, U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                                         
Networks:
LAPS-MA036, LAPS-NY016, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8321, CALGB-20202, CALGB-8461, CALGB-8721, CALGB-10502, CALGB-10801, CALGB-11001, CALGB-11002, CALGB-8821, CALGB-8921, CALGB-8923, CALGB-9420, CALGB-9720
Phases:
1, 1/2, 2, 3, N/A
Keywords: